AXIM (AXIM Biotechnologies) Tariff Resilience Score: 5/10 (As of Jun. 25, 2026)


What is AXIM Biotechnologies Tariff Resilience Score?

AXIM Biotechnologies AXIM +7.14% Tariff Resilience Score is 5 as of Jun. 25, 2026. The stock has 7 warning signs investors should review. Among 1,379 Biotechnology companies, AXIM Biotechnologies ranks better than 62.22% on this metric.

AXIM Biotechnologies has the Tariff Resilience Score of 5, which implies that the company might have Average Resilient.

AXIM Biotechnologies has Biotech firm with potential exposure to tariffs on raw materials and components. Limited scale and market presence may reduce pricing power, but innovation and niche focus offer some mitigation.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes AXIM Biotechnologies might have Average Resilient.

AXIM Biotechnologies  (OTCPK:AXIM) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

AXIM Biotechnologies Tariff Resilience Score Related Terms

AXIM vs HEPA, SCNI, BZYR: Tariff Resilience Score Comparison

For the Biotechnology subindustry, AXIM Biotechnologies's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

AXIM Biotechnologies Tariff Resilience Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, AXIM Biotechnologies's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where AXIM Biotechnologies's Tariff Resilience Score falls into.


What does a Tariff Resilience Score of 5 mean?
AXIM Biotechnologies (AXIM) has a Tariff Resilience Score of 5 as of Jun. 25, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, AXIM Biotechnologies ranks #521 out of 1379 companies in the Biotechnology industry, placing it in the top 37.8%.
Is AXIM Biotechnologies' Tariff Resilience Score too high?
AXIM Biotechnologies' current Tariff Resilience Score is 5. The Biotechnology industry median Tariff Resilience Score is 4.00. AXIM Biotechnologies' value of 5 is 25% above this industry median. Based on the distribution chart, AXIM Biotechnologies ranks #521 out of 1379 companies in the Biotechnology industry, which is above the industry midpoint.
How does AXIM Biotechnologies' Tariff Resilience Score compare to HEPA and SCNI?
According to the Biotechnology industry distribution chart, AXIM Biotechnologies ranks #521 out of 1379 companies for Tariff Resilience Score. This puts AXIM Biotechnologies in the upper half of its industry. The industry median Tariff Resilience Score is 4.00. AXIM Biotechnologies' value of 5 is 25% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Biotechnology company?
The median Tariff Resilience Score among Biotechnology companies is 4.00, based on 1,379 companies in the industry. Companies in the top quartile (top 25%) have a Tariff Resilience Score significantly above this median, while those in the bottom quartile fall well below. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. AXIM Biotechnologies's current Tariff Resilience Score of 5 is 25% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. For the Biotechnology industry, the median Tariff Resilience Score is 4.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. AXIM Biotechnologies's current Tariff Resilience Score is 5. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AXIM Biotechnologies stock overvalued right now?
AXIM Biotechnologies (AXIM) has a current Tariff Resilience Score of 5. The current Tariff Resilience Score is 5 and 25% above the Biotechnology industry median of 4.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For AXIM Biotechnologies (AXIM), the current Tariff Resilience Score is 5 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

AXIM Biotechnologies Business Description

Address 6048 Cornerstone Court West, Suite E1, San Diego, CA, USA, 92121
AXIM Biotechnologies Inc is a integrated research and development company and developer of diagnostic healthcare solutions serving to enhance the health of people. The company focuses on improving the landscape for the diagnosis of ophthalmological conditions such as Dry Eye Disease through rapid diagnostic tests. Additionally, The company owns IP and has conducted research on SARS-CoV-2 (COVID-19) rapid neutralizing antibody tests to detect levels of functional neutralizing antibodies that are believed to prevent SARS-CoV-2 from entering the host cells.